Your browser doesn't support javascript.
loading
Stochastic fate decisions of HSCs after transplantation: early contribution, symmetric expansion, and pool formation.
Radtke, Stefan; Enstrom, Mark; Pande, Dnyanada; Duke, Elizabeth R; Cardozo-Ojeda, E Fabian; Madhu, Ravishankar; Owen, Staci; Kanestrom, Greta; Cui, Margaret; Perez, Anai M; Schiffer, Joshua T; Kiem, Hans-Peter.
Affiliation
  • Radtke S; Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Enstrom M; Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Pande D; Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Duke ER; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Cardozo-Ojeda EF; Department of Medicine, University of Washington School of Medicine, Seattle, WA.
  • Madhu R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Owen S; Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Kanestrom G; Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Cui M; Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Perez AM; Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Schiffer JT; Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Kiem HP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.
Blood ; 142(1): 33-43, 2023 07 06.
Article in En | MEDLINE | ID: mdl-36821766
Hematopoietic stem cells (HSCs) are assumed to be rare, infrequently dividing, long-lived cells not involved in immediate recovery after transplantation. Here, we performed unprecedented high-density clonal tracking in nonhuman primates and found long-term persisting HSC clones to actively contribute during early neutrophil recovery, and to be the main source of blood production as early as 50 days after transplantation. Most surprisingly, we observed a rapid decline in the number of unique HSC clones, while persisting HSCs expanded, undergoing symmetric divisions to create identical siblings and formed clonal pools ex vivo as well as in vivo. In contrast to the currently assumed model of hematopoietic reconstitution, we provide evidence for contribution of HSCs in short-term recovery as well as symmetric expansion of individual clones into pools. These findings provide novel insights into HSC biology, informing the design of HSC transplantation and gene therapy studies.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cells / Hematopoietic Stem Cell Transplantation Type of study: Prognostic_studies Limits: Animals Language: En Journal: Blood Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cells / Hematopoietic Stem Cell Transplantation Type of study: Prognostic_studies Limits: Animals Language: En Journal: Blood Year: 2023 Type: Article